UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 100

Sortiert nach

Metabolism and Selective Toxicity of 6-Nitrobenzylthioinosine in Toxoplasma gondii

Antimicrobial Agents and Chemotherapy, 1999-10, Vol.43 (10), p.2437-2443

1999

Link zum Volltext

Verfügbarkeit prüfen

Pyrimidine nucleobase ligands of orotate phosphoribosyltransferase from toxoplasma gondii

Biochemical pharmacology, 1999-11, Vol.58 (9), p.1457-1466

1999

Link zum Volltext

Verfügbarkeit prüfen

Uridine phosphorylase inhibitors: Chemical modification of benzyloxybenzyl-barbituric acid and its effects on UrdPase inhibition

Bioorganic & medicinal chemistry letters, 1999-06, Vol.9 (11), p.1477-1480

1999

Link zum Volltext

Verfügbarkeit prüfen

Structure-activity relationship for the binding of nucleoside ligands to adenosine kinase from Toxoplasma gondii

Biochemical pharmacology, 1995-05, Vol.49 (10), p.1501-1512

1995

Link zum Volltext

Verfügbarkeit prüfen

Prevention of tubercidin host toxicity by nitrobenzylthioinosine 5'-monophosphate for the treatment of schistosomiasis

Antimicrobial Agents and Chemotherapy, 1989-06, Vol.33 (6), p.824-827

1989

Link zum Volltext

Verfügbarkeit prüfen

5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase

Biochemical pharmacology, 2000-09, Vol.60 (6), p.851-856

2000

Link zum Volltext

Verfügbarkeit prüfen

Intracellular Metabolism of β-l-2′,3′-Dideoxyadenosine: Relevance to Its Limited Antiviral Activity

Antimicrobial Agents and Chemotherapy, 2000-04, Vol.44 (4), p.853-858

2000

Link zum Volltext

Verfügbarkeit prüfen

Modulation of the pharmacokinetics of endogenous plasma uridine by 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for chemotherapy

Cancer chemotherapy and pharmacology, 2001-08, Vol.48 (2), p.145-150

2001

Link zum Volltext

Verfügbarkeit prüfen

Uridine phosphorylase from Schistosoma mansoni

The Journal of biological chemistry, 1988-05, Vol.263 (13), p.6081-6086

1988

Link zum Volltext

Verfügbarkeit prüfen

Modulation of 5-fluorouracil host toxicity by 5-(benzyloxybenzyl)barbituric acid acyclonucleoside, a uridine phosphorylase inhibitor, and 2′,3′,5′-tri- O-acetyluridine, a prodrug of uridine

Biochemical pharmacology, 2000-08, Vol.60 (3), p.427-431

2000

Link zum Volltext

Verfügbarkeit prüfen

The adenosine transporter of Toxoplasma gondii. Identification by insertional mutagenesis, cloning, and recombinant expression

The Journal of biological chemistry, 1999-12, Vol.274 (49), p.35255-35261

1999

Link zum Volltext

Verfügbarkeit prüfen

Enzymes of uracil catabolism in normal and neoplastic human tissues

Cancer research (Chicago, Ill.), 1985-11, Vol.45 (11), p.5405-5412

1985

Link zum Volltext

Verfügbarkeit prüfen

Combination therapy of schistosomiasis by tubercidin and nitrobenzylthioinosine 5'-monophosphate

Proceedings of the National Academy of Sciences - PNAS, 1983-11, Vol.80 (21), p.6667-6670

1983

Link zum Volltext

Verfügbarkeit prüfen

Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases : implications for chemotherapy with 5-fluoropyrimidines

Cancer research (Chicago, Ill.), 1993-08, Vol.53 (16), p.3687-3693

1993

Link zum Volltext

Verfügbarkeit prüfen

Antiviral Activity and Intracellular Metabolism of Bis(tButylSATE) Phosphotriester of β-L-2′,3'Dideoxyadenosine, a Potent Inhibitor of HIV and HBV Replication

Antiviral chemistry & chemotherapy, 2001-04, Vol.12 (2), p.99-108

2001

Link zum Volltext

Verfügbarkeit prüfen

Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2′-deoxyuridine against murine colon tumor C26–10

Biochemical pharmacology, 2000-09, Vol.60 (5), p.687-692

2000

Link zum Volltext

Verfügbarkeit prüfen

Effects of modifications in the pentose moiety and conformational changes on the binding of nucleoside ligands to uridine phosphorylase from Toxoplasma gondii

Biochemical pharmacology, 1996-06, Vol.51 (12), p.1687-1700

1996

Link zum Volltext

Verfügbarkeit prüfen

Modulation of plasma uridine concentration by 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase : relevance to chemotherapy

Cancer chemotherapy and pharmacology, 2000, Vol.45 (5), p.351-361

2000

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of 5-fluoro-2'-deoxyuridine antitumor efficacy by the uridine phosphorylase inhibitor 5-(benzyloxybenzyl)barbituric acid acyclonucleoside

Cancer research (Chicago, Ill.), 1995-03, Vol.55 (5), p.1092-1098

1995

Link zum Volltext

Verfügbarkeit prüfen

Effect of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on plasma concentration of uridine released from 2', 3', 5'-tri-O-acetyluridine, a prodrug of uridine: relevance to uridine rescue in chemotherapy

Cancer chemotherapy and pharmacology, 2000, Vol.46 (3), p.235-240

2000

Link zum Volltext

Verfügbarkeit prüfen

Insertional tagging of at least two loci associated with resistance to adenine arabinoside in Toxoplasma gondii, and cloning of the adenosine kinase locus

Molecular and biochemical parasitology, 1999-09, Vol.103 (1), p.1-14

1999

Link zum Volltext

Verfügbarkeit prüfen

Phenylselenenyl- and phenylthio-substituted pyrimidines as inhibitors of dihydrouracil dehydrogenase and uridine phosphorylase

Journal of medicinal chemistry, 1993-12, Vol.36 (26), p.4250-4254

1993

Link zum Volltext

Verfügbarkeit prüfen

Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylase

Molecular pharmacology, 1988-08, Vol.34 (2), p.104-110

1988

Link zum Volltext

Verfügbarkeit prüfen

Isolation and Partial Characterization of a 5′-nucleotidase Specific for Orotidine-5′-monophosphate

Proceedings of the National Academy of Sciences - PNAS, 1982-02, Vol.79 (4), p.1037-1041

1982

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of the bioavailability of oral uridine by coadministration of 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for uridine rescue regimens in chemotherapy

Cancer chemotherapy and pharmacology, 2001-11, Vol.48 (5), p.389-397

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(94)

Publikationsform

Artikel
(99)
Buchkapitel
(1)

Sprache

Englisch
(100)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Life Sciences & Biomedicine
(74)
Animals
(63)
Biological And Medical Sciences
(54)
Pharmacology & Pharmacy
(49)
Medical Sciences
(46)
Pharmacology. Drug Treatments
(43)
Mice
(40)
Humans
(32)
Female
(23)
Uridine Phosphorylase - Antagonists & Inhibitors
(23)
Chemotherapy
(21)
Uracil - Analogs & Derivatives
(20)
Antineoplastic Agents
(18)
Structure-Activity Relationship
(18)
Kinetics
(16)
Oncology
(16)
Biochemistry & Molecular Biology
(15)
Thioinosine - Analogs & Derivatives
(14)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metabolism and Selective Toxicity of 6-Nitrobenzylthioinosine in Toxoplasma gondii

Pyrimidine nucleobase ligands of orotate phosphoribosyltransferase from toxoplasma gondii

Uridine phosphorylase inhibitors: Chemical modification of benzyloxybenzyl-barbituric acid and its effects on UrdPase inhibition

Structure-activity relationship for the binding of nucleoside ligands to adenosine kinase from Toxoplasma gondii

Prevention of tubercidin host toxicity by nitrobenzylthioinosine 5'-monophosphate for the treatment of schistosomiasis

5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase

Intracellular Metabolism of β-l-2′,3′-Dideoxyadenosine: Relevance to Its Limited Antiviral Activity

Modulation of the pharmacokinetics of endogenous plasma uridine by 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for chemotherapy

Uridine phosphorylase from Schistosoma mansoni

Modulation of 5-fluorouracil host toxicity by 5-(benzyloxybenzyl)barbituric acid acyclonucleoside, a uridine phosphorylase inhibitor, and 2′,3′,5′-tri- O-acetyluridine, a prodrug of uridine

The adenosine transporter of Toxoplasma gondii. Identification by insertional mutagenesis, cloning, and recombinant expression

Enzymes of uracil catabolism in normal and neoplastic human tissues

Combination therapy of schistosomiasis by tubercidin and nitrobenzylthioinosine 5'-monophosphate

Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases : implications for chemotherapy with 5-fluoropyrimidines

Antiviral Activity and Intracellular Metabolism of Bis(tButylSATE) Phosphotriester of β-L-2′,3'Dideoxyadenosine, a Potent Inhibitor of HIV and HBV Replication

Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2′-deoxyuridine against murine colon tumor C26–10

Effects of modifications in the pentose moiety and conformational changes on the binding of nucleoside ligands to uridine phosphorylase from Toxoplasma gondii

Modulation of plasma uridine concentration by 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase : relevance to chemotherapy

Enhancement of 5-fluoro-2'-deoxyuridine antitumor efficacy by the uridine phosphorylase inhibitor 5-(benzyloxybenzyl)barbituric acid acyclonucleoside

Effect of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on plasma concentration of uridine released from 2', 3', 5'-tri-O-acetyluridine, a prodrug of uridine: relevance to uridine rescue in chemotherapy

Insertional tagging of at least two loci associated with resistance to adenine arabinoside in Toxoplasma gondii, and cloning of the adenosine kinase locus

Phenylselenenyl- and phenylthio-substituted pyrimidines as inhibitors of dihydrouracil dehydrogenase and uridine phosphorylase

Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylase

Isolation and Partial Characterization of a 5′-nucleotidase Specific for Orotidine-5′-monophosphate

Enhancement of the bioavailability of oral uridine by coadministration of 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for uridine rescue regimens in chemotherapy

Suchergebnisse filtern